News
More than 14 million children did not receive a single vaccine last year — about the same number as the year before — ...
2h
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
2h
The Kenya Times on MSNWHO Awards Uhuru Kenyatta for Championing Pandemic AgreementFormer President Uhuru Kenyatta has received an award from the World Health Organization (WHO). WHO formally recognized the ...
The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
The WHO’s 2025 policy brief highlights how tuberculosis disproportionately affects marginalized and high-risk populations due ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
The World Health Organization has formally recognized the pivotal role of a number of heads of state and government in securing the adoption of the WHO Pandemic Agreement by the Seventy-eighth World ...
A World Health Organization (WHO) group focused on food safety held an event recently to mark one year of existence. The WHO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results